Sanofi has moved to bolster its vaccines business by reaching a deal to buy London, UK-based biotech Vicebio, which was formed to produce improved, more potent shots that are simpler to manufacture.
Are you thinking about investing for the first time? Our guide takes you through the 10 things you need to know about investing, including what and where to buy, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results